Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Depreciation & Amortization (CF): 2021-2024

Historic Depreciation & Amortization (CF) for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $600,000.

  • Biofrontera's Depreciation & Amortization (CF) fell 15.00% to $17,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $94,000, marking a year-over-year increase of 13.25%. This contributed to the annual value of $600,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Biofrontera's Depreciation & Amortization (CF) amounted to $600,000 in FY2024, which was down 0.00% from $600,000 recorded in FY2023.
  • Biofrontera's 5-year Depreciation & Amortization (CF) high stood at $600,000 for FY2023, and its period low was $101,000 during FY2022.
  • For the 3-year period, Biofrontera's Depreciation & Amortization (CF) averaged around $433,667, with its median value being $600,000 (2024).
  • In the last 5 years, Biofrontera's Depreciation & Amortization (CF) dropped by 17.21% in 2022 and then surged by 494.06% in 2023.
  • Biofrontera's Depreciation & Amortization (CF) (Yearly) stood at $122,000 in 2021, then declined by 17.21% to $101,000 in 2022, then soared by 494.06% to $600,000 in 2023, then remained steady at $600,000 in 2024.